Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces the appointments of Elizabeth Holt as Chief Business Officer (CBO) and Dr Mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback